GROUP ONE TRADING, L.P. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 130 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q4 2020. The put-call ratio across all filers is 0.95 and the average weighting 0.3%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q3 2023$488,645
-54.1%
17,756
-43.4%
0.00%
-33.3%
Q2 2023$1,064,214
+47.0%
31,365
+55.9%
0.00%0.0%
Q1 2023$724,062
+131.8%
20,124
+187.2%
0.00%
+200.0%
Q4 2022$312,347
-19.5%
7,008
-49.2%
0.00%0.0%
Q3 2022$388,000
-49.2%
13,789
-51.3%
0.00%0.0%
Q2 2022$764,000
+13.4%
28,320
+43.2%
0.00%0.0%
Q1 2022$674,000
-61.4%
19,776
-56.3%
0.00%0.0%
Q4 2021$1,747,000
+18.8%
45,208
+65.9%
0.00%
-50.0%
Q3 2021$1,471,000
+67.3%
27,251
+3.7%
0.00%
+100.0%
Q2 2021$879,000
-48.4%
26,283
-68.2%
0.00%
-66.7%
Q1 2021$1,702,000
+302.4%
82,637
+242.1%
0.00%
+200.0%
Q4 2020$423,000
+2388.2%
24,159
+140.0%
0.00%
Q1 2020$17,000
-29.2%
10,065
-7.4%
0.00%
Q4 2019$24,000
-36.8%
10,870
-39.1%
0.00%
Q3 2019$38,000
+100.0%
17,837
+157.1%
0.00%
Q2 2019$19,000
-64.8%
6,937
-36.6%
0.00%
-100.0%
Q1 2019$54,00010,9480.00%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q4 2020
NameSharesValueWeighting ↓
Kynam Capital Management, LP 3,200,000$88,064,00014.40%
Octagon Capital Advisors LP 759,898$20,912,3933.21%
TSP Capital Management Group, LLC 251,695$6,926,6452.67%
5AM Venture Management, LLC 310,270$8,538,6302.46%
COMMODORE CAPITAL LP 706,665$19,447,4212.27%
ACUTA CAPITAL PARTNERS, LLC 122,341$3,366,8242.26%
Redmile Group, LLC 1,635,938$45,021,0142.14%
RTW INVESTMENTS, LP 3,463,201$95,307,2922.01%
Eversept Partners, LP 588,143$16,185,6951.37%
Affinity Asset Advisors, LLC 150,000$4,128,0001.16%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders